Whole Slide Imaging Market - By Type (Hardware, Software, Services), By Application (Cancer, Cardiology, Thyroid, Neurology), By End-use (Hospitals, Diagnostic Centers)

Description

List of Tables

Whole Slide Imaging Market size is anticipated to depict over 16.5% CAGR from 2023-2032, attributed to the ongoing shift toward digital healthcare solutions. Whole slide imaging (WSI) facilitates the creation of digital archives of pathology slides, making it easier to store, retrieve, and share critical medical data. It also streamlines laboratory workflows while ensuring rapid access to patient records, leading to quicker diagnoses and more efficient patient care.

Moreover, the rising integration in electronic health records (EHRs) and telemedicine along with the higher assistance in improving access to healthcare services will drive the market growth. For instance, in October 2022, AI-enabled health technology startup Pramana revealed plans to launch Digital Pathology 2.0, its next standard in whole slide imaging to demonstrate its Digital Pathology as a Service (DPaaS) solution.

The whole slide imaging market is bifurcated on the basis of type, application, end-use, and region.

Based on type, the whole slide imaging market from the software segment will witness 17.3% CAGR during 2023-2032. WSI relies heavily on sophisticated software solutions to digitize and analyze pathological slides efficiently. These software packages are at the forefront of innovation as they are continually evolving to meet the needs of healthcare providers, researchers, and pathologists. For instance, in June 2023, Evident introduced Slideview DX VS-M1 WSI system, a digital pathology solution for producing high-quality slide pictures fast and effectively to assist pathologists in making diagnoses.

The market value from the cardiology application segment is expected to expand at 16.9% growth rate through 2032. Cardiologists are increasingly recognizing the value of WSI in examining tissue samples from heart biopsies, valve surgeries, and vascular procedures. The rising number of collaborations for analyzing digital slides, making informed decisions, improving patient care, and expanding access to specialized cardiology expertise will further drive the segment growth.

Regionally, Asia Pacific whole slide imaging market is projected to depict 17.6% growth rate through 2032 attributed to increasing adoption of advanced medical technologies and the expansion of healthcare infrastructure in the region. Moreover, according to research published by the Indian Council of Medical Research and the Registrar General of India in 2022, India is responsible for almost 60% of the global burden of heart disease. This rising burden of cardiology cases is anticipated to boost the demand for WSI for cardiology applications. The growth in the telemedicine and telepathology space in remote and underserved areas will also outline the regional market development.

Product Code: 3987

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
- 1.3.1 North America
- 1.3.2 Europe
- 1.3.3 Asia Pacific
- 1.3.4 Latin America
- 1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
- 1.7.1 Secondary
  - 1.7.1.1 Paid sources
  - 1.7.1.2 Unpaid sources
- 1.7.2 Primary

Chapter 2 Executive Summary

2.1 Whole slide imaging market industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Type trends
- 2.1.4 Application trends
- 2.1.5 End-use trends

Chapter 3 Whole Slide Imaging Industry Insights

3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing demand for digital pathology solutions to enhance diagnostic accuracy
  - 3.3.1.2 Developments in whole slide imaging technology
  - 3.3.1.3 Increasing prevalence of chronic diseases
  - 3.3.1.4 Increasing drug discovery research activities
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Stringent regulatory approvals
  - 3.3.2.2 Lack of reimbursement scenario
3.4 Growth potential analysis
- 3.4.1 By type
- 3.4.2 By application
- 3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix

Chapter 5 Whole Slide Imaging Market and Forecast, By Type (USD Million)

5.1 Key trends, by type
5.2 Hardware
5.3 Software
5.4 Services

Chapter 6 Whole Slide Imaging Market and Forecast, By Application (USD Million)

6.1 Key trends, by application
6.2 Cancer
6.3 Cardiology
6.4 Thyroid
6.5 Neurology
6.6 Others

Chapter 7 Whole Slide Imaging Market and Forecast, By End-use (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic centers
7.4 Others

Chapter 8 Whole Slide Imaging Market and Forecast, By Region (USD Million)

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
- 8.3.7 Poland
- 8.3.8 Switzerland
- 8.3.9 Norway
- 8.3.10 Finland
- 8.3.11 Sweden
- 8.3.12 Denmark
- 8.3.13 The Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Taiwan
- 8.4.7 Indonesia
- 8.4.8 Vietnam
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
- 8.5.5 Chile
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Israel

Chapter 9 Company Profiles

9.1 Hamamatsu Photonics K.K.
9.2 Mikroscan Technologies, Inc.
9.3 Leica Microsystems (Danaher Corporation)
9.4 3DHISTECH (Epredia)
9.5 Koninklijke Philips N.V.
9.6 Ventana Medical Systems Inc. (Roche Holding AG)
9.7 Nikon Corporation
9.8 Indica Labs
9.9 Inspirata
9.10 Definiens (AstraZeneca)
9.11 Autoscribe Informatics
9.12 TECHNIDATA
9.13 LabSmart Healthcare Technologies
9.14 Xybion Digital Inc.